# Study : LEVOBUPIVACAINE Versus Placebo

> **NCT00621907** · PHASE3 · COMPLETED · sponsor: **Centre Hospitalier Universitaire de Saint Etienne** · enrollment: 140 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** chirocaine (Levobupivacaine)
- **DRUG:** sodium chloride

## Key facts

- **NCT ID:** NCT00621907
- **Lead sponsor:** Centre Hospitalier Universitaire de Saint Etienne
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** 2009-05
- **Final completion:** 2009-05
- **Target enrollment:** 140 (ACTUAL)
- **Last updated:** 2010-09-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00621907

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00621907, "Study : LEVOBUPIVACAINE Versus Placebo". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00621907. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*